Medprin Regenerative Medical Technologies Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004NB8
CNY
67.45
-0.47 (-0.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
273.23
226.30
193.21
153.13
122.39
111.92
84.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
273.23
226.30
193.21
153.13
122.39
111.92
84.52
Raw Material Cost
78.53
63.26
43.31
33.47
24.62
20.26
18.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
75.96
0.00
0.00
0.00
0.00
34.76
57.67
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.16
2.41
1.93
0.61
0.13
0.15
0.09
Selling and Distribution Expenses
95.20
96.96
96.15
68.39
56.89
63.42
78.15
Other Expenses
-5.21
2.19
2.60
2.35
1.47
-1.87
-3.91
Total Expenditure (Excl Depreciation)
198.79
184.53
167.42
125.94
96.36
99.85
115.45
Operating Profit (PBDIT) excl Other Income
74.4
41.8
25.8
27.200000000000003
26
12.1
-30.9
Other Income
20.05
8.29
16.43
24.31
17.47
18.44
11.41
Operating Profit (PBDIT)
122.57
76.86
58.71
60.88
49.16
36.49
-14.75
Interest
1.16
2.41
1.93
0.61
0.13
0.15
0.09
Exceptional Items
-0.33
0.13
-0.31
0.98
0.40
0.73
0.00
Gross Profit (PBDT)
194.71
163.05
149.91
119.66
97.77
91.66
65.93
Depreciation
27.91
26.55
16.51
9.65
6.43
6.01
4.80
Profit Before Tax
93.16
48.02
39.96
51.60
43.00
31.06
-19.65
Tax
14.30
7.14
4.23
6.92
6.15
3.48
-0.92
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
78.85
40.88
35.89
44.71
36.97
27.68
-18.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
78.85
40.88
35.89
44.71
36.97
27.68
-18.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-0.16
-0.03
-0.11
-0.10
-0.14
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
78.85
40.88
35.73
44.68
36.86
27.58
-18.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
699.66
635.86
602.58
572.26
334.43
299.03
271.35
Earnings per share (EPS)
1.19
0.62
0.54
0.68
0.56
0.42
-0.28
Diluted Earnings per share
1.19
0.62
0.54
0.68
0.56
0.42
-0.28
Operating Profit Margin (Excl OI)
27.3%
18.57%
13.34%
17.58%
20.64%
10.75%
-36.64%
Gross Profit Margin
44.31%
32.95%
29.23%
40.0%
40.39%
33.12%
-17.56%
PAT Margin
28.86%
18.06%
18.58%
29.2%
30.2%
24.73%
-22.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 20.72% vs 17.13% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 92.91% vs 14.57% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 49.42% vs 62.17% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -50.00% vs 26.32% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Medprin Regenerative Medical Technologies Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
273.23
0
273.23
Other Operating Income
0.00
0.00
0.00
Total Operating income
273.23
0
273.23
Raw Material Cost
78.53
0
78.53
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
75.96
0
75.96
Power Cost
0
0
0.00
Manufacturing Expenses
1.16
0
1.16
Selling and Distribution Expenses
95.20
0
95.20
Other Expenses
-5.21
0.00
-5.21
Total Expenditure (Excl Depreciation)
198.79
0
198.79
Operating Profit (PBDIT) excl Other Income
74.44
0.00
74.44
Other Income
20.05
0
20.05
Operating Profit (PBDIT)
122.57
0
122.57
Interest
1.16
0
1.16
Exceptional Items
-0.33
0
-0.33
Gross Profit (PBDT)
194.71
0
194.71
Depreciation
27.91
0
27.91
Profit Before Tax
93.16
0
93.16
Tax
14.30
0
14.30
Provisions and contingencies
0
0
0.00
Profit After Tax
78.85
0
78.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
78.85
0
78.85
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
78.85
0
78.85
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
699.66
0
699.66
Earnings per share (EPS)
1.19
0
1.19
Diluted Earnings per share
1.19
0
1.19
Operating Profit Margin (Excl OI)
27.30%
0%
0.00
27.30%
Gross Profit Margin
44.31%
0%
0.00
44.31%
PAT Margin
28.86%
0%
0.00
28.86%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 27.32 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 20.72% vs 17.13% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 7.89 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 92.91% vs 14.57% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 49.42% vs 62.17% in Dec 2023

Annual - Interest
Interest 0.12 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -50.00% vs 26.32% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.30%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023